Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ABSCFOTCMKTS:FFNTFOTCMKTS:HKMPYOTCMKTS:TGIFF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABSCFAB Science$1.60$1.58$0.80▼$1.60N/AN/A640 shsN/AFFNTF4Front Ventures$0.00-3.6%$0.01$0.00▼$0.15N/AN/A1.27 million shs87,628 shsHKMPYHikma Pharmaceuticals$53.77-0.8%$51.60$45.97▼$59.26N/AN/A933 shs521 shsTGIFF1933 Industries$0.00-20.0%$0.00$0.00▼$0.02N/AN/A111,760 shs20,750 shsFree Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABSCFAB Science0.00%0.00%+1.91%+77.78%-40.74%FFNTF4Front Ventures-3.57%+8.00%-32.50%-81.88%-96.98%HKMPYHikma Pharmaceuticals0.00%-0.07%+10.41%-8.52%+7.37%TGIFF1933 Industries-20.00%-2.04%+14.29%+77.78%-55.14%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABSCFAB ScienceN/AN/AN/AN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AN/AN/AN/AHKMPYHikma PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABSCFAB Science 0.00N/AN/AN/AFFNTF4Front Ventures 0.00N/AN/AN/AHKMPYHikma Pharmaceuticals 0.00N/AN/AN/ATGIFF1933 Industries 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABSCFAB ScienceN/AN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AN/AHKMPYHikma PharmaceuticalsN/AN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABSCFAB ScienceN/AN/A0.00∞N/AN/AN/AN/A5/13/2025 (Estimated)FFNTF4Front VenturesN/AN/A0.00∞N/AN/AN/AN/AN/AHKMPYHikma PharmaceuticalsN/A$3.1017.37∞N/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABSCFAB ScienceN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AHKMPYHikma Pharmaceuticals$0.320.60%N/A10.34%N/ATGIFF1933 IndustriesN/AN/AN/AN/AN/ALatest HKMPY, TGIFF, FFNTF, and ABSCF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/28/2025HKMPYHikma Pharmaceuticals$0.943/21/20253/21/20255/12/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABSCFAB ScienceN/AFFNTF4Front VenturesN/AHKMPYHikma PharmaceuticalsN/ATGIFF1933 IndustriesN/AInsider OwnershipCompanyInsider OwnershipABSCFAB ScienceN/AFFNTF4Front VenturesN/AHKMPYHikma PharmaceuticalsN/ATGIFF1933 IndustriesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABSCFAB Science51N/AN/ANot OptionableFFNTF4Front Ventures460N/AN/ANot OptionableHKMPYHikma Pharmaceuticals9,100N/AN/ANot OptionableTGIFF1933 Industries87N/AN/ANot OptionableHKMPY, TGIFF, FFNTF, and ABSCF HeadlinesRecent News About These Companies1933 Industries Stock Short Interest Report | OTC:TGIFF | BenzingaApril 21, 2025 | benzinga.com1933 sees uptick in revenue in NevadaApril 2, 2025 | greenmarketreport.com1933 Industries Reports Second Quarter 2025 Financial ResultsMarch 31, 2025 | accessnewswire.comCSE Bulletin: Reinstatement - 1933 Industries Inc. (TGIF)March 6, 2025 | newsfilecorp.com1933 Industries Inc.: 1933 Industries Announces First Quarter 2025 Financial ReportFebruary 28, 2025 | finanznachrichten.de1933 Industries Announces First Quarter 2025 Financial ReportFebruary 27, 2025 | accessnewswire.com1933 Industries Inc.: 1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 MillionFebruary 27, 2025 | finanznachrichten.de1933 Industries losses contract year-over-year, but company still in the redFebruary 26, 2025 | greenmarketreport.com1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 MillionFebruary 25, 2025 | accessnewswire.com1933 Industries Appoints New CFO and VP FinanceJanuary 31, 2025 | accessnewswire.com1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly ReportJanuary 24, 2025 | accessnewswire.com1933 Industries Inc.: 1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management ChangesJanuary 11, 2025 | finanznachrichten.de1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management ChangesJanuary 11, 2025 | markets.businessinsider.com1933 Industries Inc.: 1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly ReportDecember 27, 2024 | finanznachrichten.de1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly ReportDecember 27, 2024 | accesswire.com1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly ReportDecember 13, 2024 | accesswire.com1933 Industries Inc.: 1933 Industries Applies for a Management Cease Trade OrderNovember 29, 2024 | finanznachrichten.de1933 gets bumped down to the pink sheetsOctober 5, 2024 | greenmarketreport.com1933 Industries to Trade on the Pink Open MarketOctober 3, 2024 | accesswire.comLook Back: 1933 flooding trapped miners in NanticokeSeptember 16, 2024 | news.yahoo.comMedia Sentiment Over TimeHKMPY, TGIFF, FFNTF, and ABSCF Company DescriptionsAB Science OTCMKTS:ABSCF$1.60 0.00 (0.00%) As of 05/9/2025AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.4Front Ventures OTCMKTS:FFNTF$0.0027 0.00 (-3.57%) As of 05/12/2025 03:53 PM Eastern4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. The CBD Wellness segment sells non-THC hemp derived products. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.Hikma Pharmaceuticals OTCMKTS:HKMPY$53.77 -0.42 (-0.77%) As of 05/9/2025 03:37 PM EasternHikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.1933 Industries OTCMKTS:TGIFF$0.0048 0.00 (-20.00%) As of 05/12/2025 12:01 PM Eastern1933 Industries Inc., together with its subsidiaries, engages in the cultivation and production of cannabis products in the United States. It operates in three segments: the Medical Segment, the Recreational Segment, and the CBD-Infused Products Segment. The company produces, packages, and markets cannabidiol (CBD)-infused products, including tinctures, vape pens and cartridges, lotions, pain creams, gummies, and capsules under the Canna Hemp and Canna Hemp X brand names. It also offers craft-style cannabis, infused pre-rolls, full spectrum oils, distillates, terpenes, and vaporizer products; and boutique concentrates, such as shatters, crumbles, batters, sugar waxes, diamonds, and cured and live resins under the AMA and Level X brand names. The company offers its products through retail dispensaries and retail outlets, as well as through its e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. is headquartered in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Latest Deal Could Put a Freeze on Its Stock Price A 90-Day Tariff Pause Sends Alibaba Flying—BlackRock Was Ready BP Buyout Buzz Puts Spotlight on Transocean’s Comeback Potential Here's Why Call Option Traders Love Dutch Bros Stock Can Shopify Stock Make a Comeback After an Earnings Sell-Off? MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs 5 Reasons the Rebound in Microchip Technology Stock Is Real Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
